← Back to Search

A: Closure without releasing the tourniquet. for Injury

N/A
Waitlist Available
Research Sponsored by Orlando Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks, 10 weeks, 6 months.
Awards & highlights

Summary

This will be a prospective randomized clinical trial comparing clinical outcome measures in patients who undergo elective upper extremity surgery when tourniquet is dropped prior to closure as opposed to when tourniquet is dropped after closure. The study will compare objective data obtained intraoperatively as well as standard clinical outcome measures such as pain scores at routine follow up.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks, 10 weeks, 6 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks, 10 weeks, 6 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hematoma assessment
Quick DASH form
Satisfaction with surgery
+1 more

Trial Design

2Treatment groups
Active Control
Group I: A: Closure without releasing the tourniquet.Active Control1 Intervention
Tourniquet is dropped after closure.
Group II: B: Releasing the tourniquet and then closing the incisionActive Control1 Intervention
Tourniquet is dropped prior to closure.

Find a Location

Who is running the clinical trial?

Orlando Health, Inc.Lead Sponsor
31 Previous Clinical Trials
14,887 Total Patients Enrolled
~66 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top